major safety issues which means the FDA will give approval a serious consideration. of course being grey on what safety problems they really have. like lack of details and stuff but who needs details.
the FDA in 1997 decided to allow drug commercials on tv as long as they disclosed the side effects and other pertinent information. still, i dont understand how these drug commercials state over and over how a psoriasis drug may clear your skin while giving you lymphoma, other cancers, kidney failure or liver problems, but man your skin looks great.
we will be entering an era soon where they wont have to disclose those frightening facts, i am truly surprised they have to disclose it anyway today.
but guess what? the day will soon come when a newly minted BP will be advertising their new miracle drug that HAS NO SERIOUS SIDE EFFECTS and tells us its ok to take for everybody because NOBODY IS ALLERGIC TO IT and is literally safer than aspirin, tylenol, and aleve
the FDA in 1997 decided to allow drug commercials on tv as long as they disclosed the side effects and other pertinent information. still, i dont understand how these drug commercials state over and over how a psoriasis drug may clear your skin while giving you lymphoma, other cancers, kidney failure or liver problems, but man your skin looks great.
we will be entering an era soon where they wont have to disclose those frightening facts, i am truly surprised they have to disclose it anyway today.
but guess what? the day will soon come when a newly minted BP will be advertising their new miracle drug that HAS NO SERIOUS SIDE EFFECTS and tells us its ok to take for everybody because NOBODY IS ALLERGIC TO IT and is literally safer than aspirin, tylenol, and aleve
Quote:Agreed, Boat, I just looked it up, and for this unpronounceable drug "Pumitamig,"
"Grade ≥3 treatment-related adverse events (TRAEs) were reported in 17/40 (42.54%) and 13/34 (38.2%) patients in Cohorts 1 and 2, respectively, with no pumitamig-related deaths reported."
Now, the "no deaths" part is certainly promising, but I looked up what they meant by "Grade ≥3 treatment-related adverse events (TRAEs)" and we have:
"A Grade ≥3 treatment-related adverse event is a severe adverse event that is not immediately life-threatening. These events are significant enough to require medical intervention, hospitalization, or other treatments."
In short, just on safety alone, LL leaves "Pumitamig" in the dust.
5
